A Study of Attention and Memory Processes in Breast Cancer Survivors
NCT04883398
Breast Cancer Survivors, Memory Disorders
New York, United States
View Trial DetailsNCT Number: NCT02122107
In this study,the investigators are looking to see how older women who are survivors of breast cancer and either did or did not receive chemotherapy are affected by treatment, compared to older women who have never had cancer. Thinking and memory abilities normally decrease with age and the investigators want to see if the long-term effects of cancer treatments may make these problems worse. The investigators will also look at how thinking and memory abilities of older women are affected by genetics and smoking history. Genetics and other factors may affect the brain's chemicals or structure, and may either protect against the negative effects on thinking or make someone more at risk for them.
MSK participants who previously consented to allostatic blood and saliva collection but have not yet provided any allostatic blood or saliva samples for this study, will not be asked to provide any further samples at follow-up. Participants who have consented to allostatic sample collection and provided one set of allostatic blood and saliva samples at a previous follow-up study visit will still be asked to provide a second set of samples at a later follow-up. COH participants will continue to provide allostatic blood and saliva collection as originally outlined
This study is active but is not currently recruiting participants.
Notify Me60 year and older
Female
Observational
City of Hope, Duarte, California, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For cancer patients, eligibility includes:
For controls participants, eligibility includes:
°English proficiency verified through an adapted Bidimensional acculturation scale, score of 2.5 or above. ***The scale will only be administered to participants who report also speaking a language other than English.
Exclusion criteria
Time frame: up to 24 months
Neurocognitive tests will be performed longitudinally at 4 time points, enrollment, and 8, 16, and 24 months post enrollment.The participant will also be asked to complete two surveys.
Memorial Sloan Kettering Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04883398
Breast Cancer Survivors, Memory Disorders
New York, United States
View Trial DetailsNCT06073717
Behavior, Breast Cancer Survivors
Seville, Sevilla, Spain
View Trial DetailsNCT02726763
Breast Cancer Survivors
New York, United States
View Trial DetailsNCT07275957
Breast Cancer Survivors
Elche, Alicante, Spain
View Trial Details